Dr Jeremy Burrows, VP, Head of Drug Discovery, MMV
Dr Jeremy Burrows speaks with the BBC about DDD107498, a new compound that has the potential to treat malaria patients in a single dose. The details of the discovery, properties and mechanism of action of this antimalarial compound, have been published in the journal Nature. Read the press release.
Dr Thomas Spangenberg, Research Scientist, MMV
Dr. Wilfred Mbacham, Executive Director of the Multilateral Initiative on Malaria, MIM Secretariat
While governments are strengthening national and regional efforts to eliminate malaria, researchers and implementers are rising to other challenges, developing innovative solutions, tools and technologies to eliminate malaria. Some of this work was announced at the 6th Multilateral Initiative on Malaria Pan African Conference in the South African coastal city of Durban. Dr Mbacham reflects on the events that formed part of the meeting.
Dr Fatoumata Nafo-Traoré, RBM Executive Director & MMV Board Member
During the 6th MIM Pan-African Malaria Conference in Durban, South Africa, Dr Nafo-Traoré speaks about what’s being done to prevent and treat malaria on an African level.
Mr Ray Chambers, MMV's Chairman of the Board
In the lead-up to the Saving Lives in the Asia Pacific Conference, ABC Radio Australia interviews Mr Ray Chambers about the spread of drug-resistant malaria from the Greater Mekong Basin, one of the issues on the conference agenda.
Dr David Reddy, CEO, MMV
In the lead-up to the Saving Lives in the Asia Pacific Conference, ABC Radio Australia interviews Dr David Reddy about research that is paving the way for a possible single-dose malaria treatment.
Bongi Makhabela, Chief Executive Officer of the Nelson Mandela Foundation
Following the MMV-CRESIB Forum on 15 March, Bongi Makhabela, gives a rousing speech at a dinner in Barcelona, attended by Her Royal Highness Princess Cristina of Spain, on fundraising techniques, the work of the Mandela Foundation, and the need to tell positive stories of success.
“We need to continue to dream of different worlds. We need to continue to believe there is another way…We need to continue to believe in what we are doing.”
Dr. Ambrose Talisuna, Director, Access & Delivery, MMV
Uganda representative for MMV, the former head of epidemiology and surveillance for the Ministry of Health in Uganda and Sally Ethelston, director of communications and advocacy for the PATH Malaria Vaccine Initiative, discuss progress toward a malaria vaccine and the goal of eradicating the disease by 2015.
Dr Chris Hentschel, CEO, MMV
MMV’s President and CEO Chris Hentschel is interviewed by Sky Radio Network and speaks about MMV and its contribution to the goal of malaria eradication.